… double-blind, randomized, placebo-controlled trials that compare the antipsychotic effects for
acute psychosis … Further studies evaluating the effects of QTP-ER in the low-dose range are …

… placebo effect added via a linear model featuring a “drift” parameter reflecting the progression
of the disease and the placebo … verified only in patients with schizophrenia. Additionally, …

… Patients meeting DSM-5 criteria for bipolar I depression were randomized to 6 weeks of
double-blind, placebo-controlled treatment with SEP-4199 200 mg/d or 400 mg/d. The primary …

… evidence that the difference in adverse events between high- and low-dose groups was …
compared with the placebo group, but evidence has rarely been provided for the comparison …

Objectives The second-generation antipsychotic quetiapine has been demonstrated to
undergo gestation-related changes in pharmacokinetics. This study applied pharmacokinetic …

… double-blind randomized registration studies in nonelderly … Finally, four RCTs compared
low-dose risperidone with other … [Citation93] compared risperidone with quetiapine. This was …

… with high-dose quetiapine than low-dose quetiapine and placebo (5). The … double-blind
RCT assessing quetiapine in patients with primary insomnia showed some benefit with low-dose …

… The patient recovered on low-dose amisulpride, a … against the negative symptoms of
schizophrenia, with the rationale … reasons having to do with placebo responses and an effect …

… progressed well, or to reduce to a very low dose, defined as the equivalent of 2 mg of …
which found that 26% of those transferred to placebo were readmitted, compared with 10% …

… under treatment compared with control. We included double-blind, placebo-controlled, …
For example, for quetiapine we found that patients differed in their susceptibility for weight …